The psychedelic drugs market will grow at highest pace owing to rising prevalence of mental health disorders. Psychedelic drugs contain psychedelic substances like psilocybin, LSD, mescaline, and DMT that can positively impact mental health issues like depression, anxiety, PTSD, addiction and others. These drugs work by altering the serotonin levels in the brain and induce hallucinogenic effects. The psychedelic drugs market is currently growing with the revival of medical research into these drugs for treating mental health conditions. Studies show psychedelic therapies can effectively treat mental disorders with long lasting effects and fewer side effects than existing antidepressants.
The Psychedelic Drugs Market is estimated to be valued at US$ 2.7 Bn in 2024 and is expected to exhibit a CAGR of 15% over the forecast period 2024-2031.
Key Takeaways
Key players operating in the psychedelic drugs are Celon Pharma, iX Biopharma, Lykos Therapeutics, MindMed, Janssen Pharmaceuticals. Celon Pharma is a clinical stage biotech company focused on developing therapies for mental illness using psychedelic substances. iX Biopharma is developing drugs containing psilocybin to treat conditions like cancer-related depression and PTSD.
The demand for psychedelic drugs is growing sharply as prevalence of mental health disorders rises worldwide. According to WHO, over 300 million people are now living with depression. Psychedelic drug research can help address this huge mental healthcare need.
Technological advancements are also helping accelerate the development of psychedelic drugs. For example, genetic research is helping identify how psychedelic substances interact with the brain at molecular level. Brain imaging techniques are elucidating their precise mechanisms of action. This improves drug discovery and development process.
Market Trends
Microdosing of psychedelics is gaining traction as an alternative treatment method. Microdosing involves consuming sub-perceptual doses of LSD or psilocybin on a regular basis to attain therapeutic benefits without hallucinogenic effects.
Combination therapies using psychedelics with other established treatments like talk therapy is being explored. This aims to enhance therapeutic outcomes through drug-assisted psychotherapy protocols.
Market Opportunities
Psychedelic drugs show promise in treating addiction disorders like alcohol use disorder, opioid addiction etc. Studies found a single dose of psilocybin can significantly reduce alcohol consumption and craving for months.
Expansion into new regions by conducting clinical trials beyond traditional markets can help companies tap newer geographies and accelerate commercialization of psychedelic therapies.
Impact Of COVID-19 On Psychedelic Drugs Market Growth
The COVID-19 pandemic has had a significant impact on the psychedelic drugs market growth. During the initial lockdown phases, the demand for psychedelic assisted therapies declined significantly as therapists moved towards online service delivery models which are still evolving. Meeting in-person for psychedelic therapy sessions was challenging due to social distancing norms. This disrupted the treatment process and affected the market revenue in the short term.
However, with rising mental health issues like anxiety, depression and substance abuse during the pandemic, the need for alternative treatment options has increased. The long wait periods for conventional therapies have led more individuals to explore psychedelic drugs for treatment-resistant conditions. Telehealth and digital platforms are also enabling therapists to support clients remotely. This has enabled the market to bounce back faster than expected in the post-COVID phase. Companies are accelerating their clinical trial processes and developing effective micro-dosing and home-use treatment models. The growing focus on mental health post-pandemic is projected to boost the acceptance and adoption of psychedelic therapies over the coming years.
Geographical Regions With High Psychedelic Drugs Market Value
North America currently dominates the psychedelic drugs market and accounts for the largest market share in terms of value. This is attributed to factors like the growing prevalence of mental health disorders, fast adoption of advanced therapies, supportive regulation for research, and presence of key market players in the region. The US has emerged as a major investment hub for psychedelic drug research and development. It is projected to continue dominating the regional market over the forecast period.
Fastest Growing Regional Market For Psychedelic Drugs
Europe is expected to demonstrate the fastest growth in the psychedelic drugs market over the coming years. This is due to the rapidly changing regulatory environment favoring psychedelic drug research and trials. Countries like the UK, Germany, Netherlands are at the forefront of regulating medical use of substances like psilocybin and MDMA to treat various mental conditions. Increasing awareness about mental health, rising healthcare expenditure, and growing geriatric population are fueling market opportunities. Europe is predicted to offer lucrative expansion prospects for psychedelic drug manufacturers in the coming decade.
Get more insights on this topic: https://www.pressreleasebulletin.com/psychedelic-drugs-market-poised-to-witness-high-growth-due-to-increasing-rd-of-psychedelic-therapies/
Author Bio:
Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemical and materials, defense and aerospace, consumer goods, etc. (https://www.linkedin.com/in/money-singh-590844163 )
What Are The Key Data Covered In This Psychedelic Drugs Market Report?
:- Market CAGR throughout the predicted period
:- Comprehensive information on the aspects that will drive the Psychedelic Drugs Market's growth between 2024 and 2031.
:- Accurate calculation of the size of the Psychedelic Drugs Market and its contribution to the market, with emphasis on the parent market
:- Realistic forecasts of future trends and changes in consumer behaviour
:- Psychedelic Drugs Market Industry Growth in North America, APAC, Europe, South America, the Middle East, and Africa
:- A complete examination of the market's competitive landscape, as well as extensive information on vendors
:- Detailed examination of the factors that will impede the expansion of Psychedelic Drugs Market vendors
FAQ’s
Q.1 What are the main factors influencing the Psychedelic Drugs Market?
Q.2 Which companies are the major sources in this industry?
Q.3 What are the market’s opportunities, risks, and general structure?
Q.4 Which of the top Psychedelic Drugs Market companies compare in terms of sales, revenue, and prices?
Q.5 Which businesses serve as the Psychedelic Drugs Market’s distributors, traders, and dealers?
Q.6 How are market types and applications and deals, revenue, and value explored?
Q.7 What does a business area’s assessment of agreements, income, and value implicate?
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
Comments
0 comment